Publications by authors named "Anke Schulz"

Claim this Profile
S
Safety and activity of anti-mesothelin antibody-drug conjugate anetumab ravtansine in combination with pegylated-liposomal doxorubicin in platinum-resistant ovarian cancer: multicenter, phase Ib dose escalation and expansion study.
Alessandro D Santin, Ignace Vergote, Antonio González-Martín, Kathleen Moore, Ana Oaknin, Anke Schulz

Int J Gynecol Cancer· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performing Meta-analyses with Very Few Studies.
Anke Schulz, Christoph Schürmann, Guido Skipka, Ralf Bender

Methods Mol Biol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Systematic Approach for Post Hoc Subgroup Analyses With Applications in Clinical Case Studies.
Christoph Muysers, Alex Dmitrienko, Hermann Kulmann, Bodo Kirsch, Susanne Lippert, Anke Schulz

Ther Innov Regul Sci· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Rivaroxaban on Biomarkers of Coagulation and Inflammation: A Post Hoc Analysis of the X-VeRT Trial.
Paulus Kirchhof, Michael D Ezekowitz, Yanish Purmah, Sonja Schiffer, Isabelle L Meng, Anke Schulz

TH Open· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Systematic Approach for Post Hoc Subgroup Analyses With Applications in Clinical Case Studies.
Christoph Muysers, Alex Dmitrienko, Hermann Kulmann, Bodo Kirsch, Susanne Lippert, Anke Schulz

Ther Innov Regul Sci· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: biomarker substudy results from a prospective study with rivaroxaban (X-TRA).
Kazuo Miyazawa, Daniele Pastori, Christoph Hammerstingl, Riccardo Cappato, Isabelle Ling Meng, Anke Schulz

Ann Med· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II Study of Refametinib (BAY 86-9766) in Combination with Gemcitabine in Advanced Pancreatic cancer.
Jean-Luc Van Laethem, Hanno Riess, Jacek Jassem, Michael Haas, Uwe M Martens, Anke Schulz

Target Oncol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AKT1 (E17K) mutation profiling in breast cancer: prevalence, concurrent oncogenic alterations, and blood-based detection.
Marion Rudolph, Tobias Anzeneder, Anke Schulz, Georg Beckmann, Annette T Byrne

BMC Cancer· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sharing pharma compounds with academia: experiences with providing vitamin D receptor ligands.
Arndt A Schmitz, Sandra Hackethal, Anke Schulz, Ekkehard May, Andreas Steinmeyer

Nat Rev Drug Discov· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytokeratin-19 as a biomarker in urine and in serum for the diagnosis of endometriosis--a prospective study.
Lorenz Kuessel, Agnes Jaeger-Lansky, Petra Pateisky, Nora Rossberg, Anke Schulz

Gynecol Endocrinol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Entropy-supported marker selection and Mantel statistics for haplotype sharing analysis.
Anke Schulz, Christine Fischer, Jenny Chang-Claude, Lars Beckmann

Genet Epidemiol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Representation of genetic association via attributable familial relative risks in order to identify polymorphisms functionally relevant to rheumatoid arthritis.
Justo Lorenzo Bermejo, Christine Fischer, Anke Schulz, Nadine Cremer, Rebecca Hein

BMC Proc· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis